These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

839 related items for PubMed ID: 14729589

  • 1. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G, Davies BR, Vass JK, Siddiqui N, Brown R.
    Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
    [Abstract] [Full Text] [Related]

  • 2. Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy.
    Strathdee G, Vass JK, Oien KA, Siddiqui N, Curto-Garcia J, Brown R.
    Gynecol Oncol; 2005 Jun; 97(3):898-903. PubMed ID: 15894365
    [Abstract] [Full Text] [Related]

  • 3. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, Leu YW, Liu JC, Huang TH.
    Cancer Res; 2003 Oct 01; 63(19):6178-86. PubMed ID: 14559801
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C, Song JZ, Davidson B, Clark SJ.
    Cancer Res; 2004 Jun 01; 64(11):3871-7. PubMed ID: 15172996
    [Abstract] [Full Text] [Related]

  • 5. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC.
    Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529
    [Abstract] [Full Text] [Related]

  • 6. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.
    Shridhar V, Bible KC, Staub J, Avula R, Lee YK, Kalli K, Huang H, Hartmann LC, Kaufmann SH, Smith DI.
    Cancer Res; 2001 May 15; 61(10):4258-65. PubMed ID: 11358853
    [Abstract] [Full Text] [Related]

  • 7. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia.
    Strathdee G, Sim A, Soutar R, Holyoake TL, Brown R.
    Carcinogenesis; 2007 Feb 15; 28(2):299-309. PubMed ID: 16861263
    [Abstract] [Full Text] [Related]

  • 8. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH, Montgomery JS, Starkey JA, Novotny M, Zuhowski EG, Egorin MJ, Moseman AP, Golas A, Brannon KM, Balch C, Huang TH, Nephew KP.
    Cancer Res; 2006 Jun 01; 66(11):5582-91. PubMed ID: 16740693
    [Abstract] [Full Text] [Related]

  • 9. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 01; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors.
    Kikuchi T, Toyota M, Itoh F, Suzuki H, Obata T, Yamamoto H, Kakiuchi H, Kusano M, Issa JP, Tokino T, Imai K.
    Oncogene; 2002 Apr 18; 21(17):2741-9. PubMed ID: 11965547
    [Abstract] [Full Text] [Related]

  • 11. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
    Bhakat KK, Mitra S.
    Carcinogenesis; 2003 Aug 18; 24(8):1337-45. PubMed ID: 12807730
    [Abstract] [Full Text] [Related]

  • 12. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
    Soejima H, Nakagawachi T, Zhao W, Higashimoto K, Urano T, Matsukura S, Kitajima Y, Takeuchi M, Nakayama M, Oshimura M, Miyazaki K, Joh K, Mukai T.
    Oncogene; 2004 May 27; 23(25):4380-8. PubMed ID: 15007390
    [Abstract] [Full Text] [Related]

  • 13. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays.
    Nouzova M, Holtan N, Oshiro MM, Isett RB, Munoz-Rodriguez JL, List AF, Narro ML, Miller SJ, Merchant NC, Futscher BW.
    J Pharmacol Exp Ther; 2004 Dec 27; 311(3):968-81. PubMed ID: 15302897
    [Abstract] [Full Text] [Related]

  • 14. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ.
    Hum Mol Genet; 2009 Aug 15; 18(16):3098-109. PubMed ID: 19477956
    [Abstract] [Full Text] [Related]

  • 15. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J.
    Cancer Res; 2003 Feb 01; 63(3):664-73. PubMed ID: 12566312
    [Abstract] [Full Text] [Related]

  • 16. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
    Ahluwalia A, Hurteau JA, Bigsby RM, Nephew KP.
    Gynecol Oncol; 2001 Aug 01; 82(2):299-304. PubMed ID: 11531283
    [Abstract] [Full Text] [Related]

  • 17. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
    Czekierdowski A, Czekierdowska S, Danilos J, Czuba B, Sodowski K, Sodowska H, Szymanski M, Kotarski J.
    J Physiol Pharmacol; 2008 Sep 01; 59 Suppl 4():53-65. PubMed ID: 18955754
    [Abstract] [Full Text] [Related]

  • 18. The role of CpG methylation in cell type-specific expression of the aquaporin-5 gene.
    Nomura J, Hisatsune A, Miyata T, Isohama Y.
    Biochem Biophys Res Commun; 2007 Feb 23; 353(4):1017-22. PubMed ID: 17198683
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion.
    Simpson DJ, Clayton RN, Farrell WE.
    Oncogene; 2002 Feb 14; 21(8):1217-24. PubMed ID: 11850841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.